Crohn Disease: all 1,923 studies
Page 20 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.
- STA-5326 in Crohn's Disease PatientsCompletedNCT00088062Phase 1/2
- A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's DiseaseCompletedNCT00078611Phase 3
- Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00077779Phase 3
- An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's DiseaseCompletedNCT00074542Phase 3
- A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's DiseaseCompletedNCT00072943Phase 2
- Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's DiseaseCompletedNCT00072839Phase 2
- Quality of Life in Pediatric Inflammatory Bowel DiseaseCompletedNCT00061737
- Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's DiseaseCompletedNCT00056355Phase 1
- Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's DiseaseCompletedNCT00055536Phase 2
- A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00055523Phase 2
- Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's DiseaseCompletedNCT00055367Phase 2
- Alicaforsen (ISIS 2302) in Patients With Active Crohn's DiseaseCompletedNCT00048295Phase 3
- Alicaforsen (ISIS 2302) in Patients With Active Crohn's DiseaseCompletedNCT00048113Phase 3
- CP-461 for the Treatment of Crohn's DiseaseCompletedNCT00042055Phase 2
- Study Evaluating rhIL-11 in Active Crohn's DiseaseCompletedNCT00040521Phase 2
- CNI-1493 for Treatment of Moderate to Severe Crohn's DiseaseTerminatedNCT00038766Phase 2
- Multicenter Trial For Patients With Acute Crohn's DiseaseCompletedNCT00035503Phase 2
- Safety and Efficacy of Natalizumab in the Treatment of Crohn's DiseaseCompletedNCT00032799Phase 3
- Safety and Efficacy of Natalizumab in the Treatment of Crohn's DiseaseCompletedNCT00032786Phase 3
- G-CSF to Treat Crohn's DiseaseCompletedNCT00025805Phase 1
- Monoclonal Antibody Treatment of Crohn's DiseaseCompletedNCT00007163Phase 1
- Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's DiseaseCompletedNCT00004941Phase 3
- Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's DiseaseCompletedNCT00004423Not applicable